IOL CHEMICALS & PHARM. | HESTER BIOSCIENCES | IOL CHEMICALS & PHARM./ HESTER BIOSCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 89.5 | 15.3% | View Chart |
P/BV | x | 1.6 | 5.1 | 30.3% | View Chart |
Dividend Yield | % | 1.0 | 0.5 | 211.5% |
IOL CHEMICALS & PHARM. HESTER BIOSCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
HESTER BIOSCIENCES Mar-23 |
IOL CHEMICALS & PHARM./ HESTER BIOSCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 2,852 | 18.8% | |
Low | Rs | 272 | 1,416 | 19.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 312.7 | 120.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 32.9 | 71.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 57.3 | 55.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 8.00 | 50.0% | |
Avg Dividend yield | % | 1.0 | 0.4 | 263.8% | |
Book value per share (Unadj.) | Rs | 256.8 | 328.7 | 78.1% | |
Shares outstanding (eoy) | m | 58.71 | 8.51 | 689.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 6.8 | 15.7% | |
Avg P/E ratio | x | 17.1 | 64.7 | 26.4% | |
P/CF ratio (eoy) | x | 12.8 | 37.3 | 34.4% | |
Price / Book Value ratio | x | 1.6 | 6.5 | 24.3% | |
Dividend payout | % | 16.9 | 24.3 | 69.5% | |
Avg Mkt Cap | Rs m | 23,743 | 18,152 | 130.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 560 | 300.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 2,661 | 833.2% | |
Other income | Rs m | 256 | 154 | 166.8% | |
Total revenues | Rs m | 22,427 | 2,814 | 796.8% | |
Gross profit | Rs m | 2,257 | 548 | 411.7% | |
Depreciation | Rs m | 462 | 207 | 223.0% | |
Interest | Rs m | 165 | 93 | 176.7% | |
Profit before tax | Rs m | 1,887 | 402 | 469.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 121 | 408.5% | |
Profit after tax | Rs m | 1,391 | 280 | 496.3% | |
Gross profit margin | % | 10.2 | 20.6 | 49.4% | |
Effective tax rate | % | 26.2 | 30.2 | 87.0% | |
Net profit margin | % | 6.3 | 10.5 | 59.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,276 | 424.7% | |
Current liabilities | Rs m | 5,025 | 1,487 | 338.0% | |
Net working cap to sales | % | 20.9 | 29.7 | 70.6% | |
Current ratio | x | 1.9 | 1.5 | 125.7% | |
Inventory Days | Days | 43 | 47 | 91.7% | |
Debtors Days | Days | 8 | 109 | 7.6% | |
Net fixed assets | Rs m | 11,017 | 4,424 | 249.1% | |
Share capital | Rs m | 587 | 85 | 690.1% | |
"Free" reserves | Rs m | 14,490 | 2,712 | 534.3% | |
Net worth | Rs m | 15,077 | 2,797 | 539.0% | |
Long term debt | Rs m | 0 | 1,849 | 0.0% | |
Total assets | Rs m | 20,684 | 6,700 | 308.7% | |
Interest coverage | x | 12.5 | 5.3 | 234.6% | |
Debt to equity ratio | x | 0 | 0.7 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.4 | 269.9% | |
Return on assets | % | 7.5 | 5.6 | 134.9% | |
Return on equity | % | 9.2 | 10.0 | 92.1% | |
Return on capital | % | 13.6 | 10.6 | 127.8% | |
Exports to sales | % | 26.7 | 11.6 | 230.5% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 309 | 1,920.3% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 309 | 1,920.3% | |
Fx outflow | Rs m | 6,052 | 39 | 15,617.5% | |
Net fx | Rs m | -122 | 270 | -45.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 236 | 518.2% | |
From Investments | Rs m | -1,200 | -770 | 155.8% | |
From Financial Activity | Rs m | -41 | 418 | -9.8% | |
Net Cashflow | Rs m | -18 | -116 | 15.9% |
Indian Promoters | % | 48.2 | 44.3 | 108.8% | |
Foreign collaborators | % | 0.0 | 9.5 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.4 | 395.3% | |
FIIs | % | 1.4 | 0.4 | 325.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 46.3 | 112.0% | |
Shareholders | 130,003 | 12,844 | 1,012.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | HESTER PHARM | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | 1.88% | 0.45% |
1-Month | 5.76% | 20.70% | 2.55% |
1-Year | -2.63% | -6.68% | 56.14% |
3-Year CAGR | -12.88% | -7.49% | 15.22% |
5-Year CAGR | 16.82% | 2.93% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the HESTER PHARM share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of HESTER PHARM the stake stands at 53.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of HESTER PHARM.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
HESTER PHARM paid Rs 8.0, and its dividend payout ratio stood at 24.3%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of HESTER PHARM.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.